在前列腺癌中,SPOP突变通过CK2/PIAS1/SPOP轴增加了PARP抑制剂的敏感性
Hui Zhang1, Lili Kong2, Jinhui Li1
1Department of Urology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, China.
JCI insight
|April 22, 2025
概括
患有SPOP突变的前列腺癌 (PCa) 细胞表现出基因组不稳定性和对PARP抑制剂 (如olaparib) 的敏感性增加. 干扰CK2/PIAS1/SPOP轴会损害DNA损伤修复 (DDR),从而提高olaparib的疗效.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 前列腺癌 (PCa) 中受损的DNA损伤修复 (DDR) 增加了对PARP抑制剂的敏感性,但机制尚不清楚.
- 基因组不稳定是癌症的标志,特别是在PCa.
- 在PCa病例的一个子集中发现了SPOP基因突变.
研究的目的:
- 阐明将SPOP突变,基因组不稳定性和PCa中的PARP抑制剂敏感性联系在一起的机制.
- 调查CK2/PIAS1/SPOP轴在DDR和PCa细胞对olaparib.com的反应中的作用.
主要方法:
- 对SPOP突变PCa细胞中的基因组不稳定性的分析.
- 在SPOP突变PCa细胞中评估olaparib诱导的亡.
- 调查CK2介导PIAS1的酸化及其对SPOP SUMOylation和E3结合酶活性的影响.
- 在PCa模型和患者衍生器官中评估CK2/PIAS1/SPOP轴.
- 测试SPOP抑制剂对DDR和olaparib敏感性的影响.
主要成果:
- 具有SPOP突变的PCa细胞表现出深刻的基因组不稳定性和对olaparib的高度敏感性.
- 奥拉巴里布诱导PIAS1-S468的CK2介导酸化,促进DDR中的SPOP SUMOylation和E3结合酶活性.
- 通过SPOP突变或受损的CK2酸化,对CK2/PIAS1/SPOP轴的干扰会导致缺陷的DDR.
- 损伤的DDR增强了PCa细胞中的olaparib诱导的亡,在临床前模型中改善了olaparib敏感性.
结论:
- 在PCa中,CK2/PIAS1/SPOP信号轴在调节DDR方面发挥着至关重要的作用.
- 这个轴上的SPOP突变或缺陷会对PARP抑制剂产生敏感性.
- 干扰CK2 / PIAS1 / SPOP轴作为一个潜在的生物标志物用于针对性PCa治疗与PARP抑制剂.
相关概念视频
Abnormal Proliferation
4.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.3K
DNA Damage can Stall the Cell Cycle
9.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.0K
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
Interactions Between Signaling Pathways
6.1K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.1K
Negative Regulator Molecules
35.0K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.0K


